Bill > SF205

This bill amends Minnesota state law to prohibit prior authorization for antineoplastic cancer treatment that is consistent with National Comprehensive Cancer Network guidelines or other nationally and internationally accepted standards of care. Specifically, the bill removes previous language that allowed prior authorization for cancer treatment medications and eliminates the requirement for processing prior authorization requests through specific administrative procedures. The legislation means that health insurance companies, utilization review organizations, and claims administrators will no longer be able to require pre-approval before a patient can receive cancer treatments. This change is designed to reduce administrative barriers that might delay critical cancer care, ensuring patients can more quickly access treatments recommended by medical professionals. The bill will take effect on January 1, 2027, and will apply to health benefit plans offered, sold, issued, or renewed on or after that date, giving health insurers and healthcare systems time to adjust their processes to comply with the new requirement.

Business and Industry, Health and Social Services

https://www.revisor.mn.gov/bills/bill.php?b=Senate&f=SF0205&ssn=0&y=2025